pharma · Bleeding Complication During Colon Polypectomy · Cancer of Colon
Yang Xiaotian
Yang Xiaotian is a pharma organization headquartered in CN. Primary therapeutic focus areas include Bleeding Complication During Colon Polypectomy, Cancer of Colon, Erosive Esophagitis, Gastric Cancer, Primary Aldosteron
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 5
- Drugs
- 2
- Patents
- 0
Ilaprazole
Phase 3 · small molecule · Erosive Esophagitis
Ilaprazole for Erosive Esophagitis is a Phase 3 program (small_molecule) at Yang Xiaotian with 1 ClinicalTrials.gov record(s).
Internal code IY-81149-EE03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Yang Xiaotian
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Erosive Esophagitis
- Status
- completed
- Trials
- 1